These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7911308)

  • 21. Terazosin for hypertension.
    Med Lett Drugs Ther; 1987 Dec; 29(755):112-3. PubMed ID: 2891021
    [No Abstract]   [Full Text] [Related]  

  • 22. The mechanism of adverse events associated with terazosin: an analysis of the Veterans Affairs cooperative study.
    Lepor H; Jones K; Williford W
    J Urol; 2000 Apr; 163(4):1134-7. PubMed ID: 10737482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension.
    Achari R; Hosmane B; Linnen P; Cavanaugh J; Baroldi P; Cohen A
    J Clin Pharmacol; 1998 Jun; 38(6):545-53. PubMed ID: 9650545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and safety of terazosin for the treatment of symptomatic BPH.
    Lepor H; Henry D; Laddu AR
    Prostate; 1991; 18(4):345-55. PubMed ID: 1711689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR; Glassman HN; Estep CB; Maurath CJ; Jordan DC
    Am Heart J; 1989 Apr; 117(4):842-7. PubMed ID: 2564723
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraoperative floppy-iris syndrome associated with systemic alpha blockers.
    Mamalis N
    J Cataract Refract Surg; 2008 Jul; 34(7):1051-2. PubMed ID: 18571055
    [No Abstract]   [Full Text] [Related]  

  • 27. The safety and efficacy of terazosin for the treatment of benign prostatic hyperplasia.
    Lepor H; Knapp-Maloney G; Wozniak-Petrofsky J
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):392-7. PubMed ID: 2477339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Side effects of terazosin in the treatment of symptomatic benign prostatic hyperplasia.
    McKiernan JM; Lowe FC
    South Med J; 1997 May; 90(5):509-13. PubMed ID: 9160069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The value of alpha-blockers in the management of hypertension: a practical view.
    McInnes GT
    J Hum Hypertens; 1991 Aug; 5(4):313-6. PubMed ID: 1683406
    [No Abstract]   [Full Text] [Related]  

  • 30. [Terazosin].
    Schäfers RF; Michel MC
    Dtsch Med Wochenschr; 1998 Apr; 123(15):459-60. PubMed ID: 9581161
    [No Abstract]   [Full Text] [Related]  

  • 31. Terazosin in benign prostatic hyperplasia: effects on blood pressure in normotensive and hypertensive men.
    Kirby RS
    Br J Urol; 1998 Sep; 82(3):373-9. PubMed ID: 9772873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy of terazosin for treating benign prostatic hyperplasia: a multicentre clinical trial.
    Miekos E; Trzepizur Z; Rózanski W; Boniecki R; Kusnierz J; Jablonowski Z; Zydek C
    BJU Int; 2002 May; 89(7):771-2. PubMed ID: 11966644
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of intracameral phenylephrine in the management of intraoperative floppy-iris syndrome with doxazosin.
    Williams GP; Tsaloumas MD
    Eye (Lond); 2008 Aug; 22(8):1094. PubMed ID: 18327163
    [No Abstract]   [Full Text] [Related]  

  • 34. Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events.
    Somberg JC; Achari R; Laddu AR
    Am Heart J; 1991 Sep; 122(3 Pt 2):901-5. PubMed ID: 1678920
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term efficacy and safety of terazosin.
    Cohen J
    J Clin Pharmacol; 1993 Mar; 33(3):272-8. PubMed ID: 8096524
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of fiduxosin, an antagonist selective for alpha(1A)- and alpha(1D)-adrenoceptors, on intraurethral and arterial pressure responses in conscious dogs.
    Brune ME; Katwala SP; Milicic I; Witte DG; Kerwin JF; Meyer MD; Hancock AA; Williams M
    J Pharmacol Exp Ther; 2002 Feb; 300(2):487-94. PubMed ID: 11805208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged penile erection association with terazosin in a cervical spinal cord injury patient.
    Vaidyanathan S; Soni BM; Singh G; Sett P; Krishnan KR
    Spinal Cord; 1998 Nov; 36(11):805. PubMed ID: 9848493
    [No Abstract]   [Full Text] [Related]  

  • 38. Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis.
    Lowe FC
    Urology; 1994 Jul; 44(1):46-51. PubMed ID: 7518981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between terazosin dose and blood pressure response in hypertensive patients.
    Achari R; Hosmane B; Bonacci E; O'Dea R
    J Clin Pharmacol; 2000 Oct; 40(10):1166-72. PubMed ID: 11028256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effectiveness of terazosin: a new long-acting alpha-adrenergic inhibitor.
    Chrysant SG; Bal IS; Johnson B; McPherson MA
    Clin Cardiol; 1985 Sep; 8(9):486-9. PubMed ID: 2864153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.